Cairo – Mubasher: The modified unaudited financial results of Alexandria Co. for Pharmaceuticals and Chemical Industries reported EGP 170.04 million in net profits during fiscal year 2019/2020, rising by 50.7% year-on-year (YoY) from EGP 112.8 million.

The company generated EGP 1.02 billion in sales during the 12-month period ended 30 June, up from EGP 829 million a year earlier, according to a bourse filing on Sunday.

During the first 11 months, Alexandria Pharmaceuticals achieved net profits of EGP 150.56 million, compared to EGP 112.6 million in the year-ago period.